Stay updated on Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.

Latest updates to the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page
- Check5 days agoChange DetectedNew help and join-related sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the recruitment status now shows 'No longer looking for participants'. The 'Intervention/Treatment' label was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check12 days agoChange DetectedThe revision label on the page has been updated to v3.5.5, replacing the previous v3.5.4. This indicates a new page version rather than substantive content changes.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision tag was updated to v3.5.4 (replacing v3.5.3), indicating a new version of the page. This appears to be routine maintenance and does not alter study content or user-facing information.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page's revision label was updated from v3.5.2 to v3.5.3, reflecting a minor update to the page's version history.SummaryDifference0.1%

- Check62 days agoChange DetectedFooter revision tag changed from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page footer lists Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.